Companies / Pegbio
Pegbio
Hangzhou, China
Pegbio is a biotechnology company that researches and develops innovative therapies for chronic diseases, particularly in the field of endocrine metabolism.
Pegbio, based in Hangzhou, China, has 2 investors on file, among them Legend Star and TF Capital. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Legend Star
43 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (25%), AI & Machine Learning (24%), Industrial & Manufacturing (18%).
More from TF Capital
13 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (85%), Robotics & Hardware (8%), AI & Machine Learning (8%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Pegbio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Legend Star adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/pegbio.com/investors
# also
GET /v1/companies/pegbio.com
GET /v1/companies/pegbio.com/news